The primary objective of this study was to determine the inter-rater reliability of the revised version of the Edmonton Functional Assessment Tool (EFAT-2). A second objective was to determine whether both formally trained and self-trained therapists had an acceptable level of inter-rater reliability. The EFAT-2 was administered to consenting palliative care patients by one of two independent physical therapist rater pairs; one pair self-trained (R1, R2) and the other formally trained (R3, R4). The intraclass correlation [ICC (1,1)] for R1, R2 was 0.97 [95% confidence interval (CI) 0.94-0.99] and for R3, R4 was 0.95 (95% CI 0.90-0.98). The standard error of measurement was 1.09 and 1.44, respectively. The Kappa statistic for the rater pairs on individual EFAT items ranged from 0.17 to 0.96. The results suggest that both formally trained and self-trained therapists obtain an acceptable level of inter-rater reliability when using the EFAT-2.
Introduction
As the specialty of palliative care has grown so has the contribution of rehabilitation in that milieu. 1 As a result, physical therapists are actively involved in rehabilitation of people with cancer during all phases of the disease. 2 Although rehabilitation therapists observe changes in the way in which patients function during palliative care, such changes are not well described in the literature. 3 A comprehensive evaluation of functional status is needed to describe how patients with a palliative diagnosis perform activities important to everyday functioning at various intervals during their care. An evaluation is also needed to measure how rehabilitation affects the way in which a patient functions in palliative care. As with measurement in all stages of the cancer trajectory, measures in palliative care must be sensitive, valid and reliable. 4 Some generic rehabilitation measures have been used in oncology but few are specific to functional performance measured by physical therapists in palliative care. [4] [5] [6] One of the measures, the Edinburgh Rehabilitation Status Scale (ERSS), may be pertinent to functions assessed by physical therapists. It has been used to assess the rehabilitation needs of women with metastatic breast cancer. The Functional Independence Measure (FIM) has been used to evaluate functional outcome following rehabilitation of the cancer patient in the 'prepalliative' phase of the disease. 5, 6 There is no documentation in the literature describing its use in a palliative setting. The poor physical condition of most patients with advanced cancer would necessitate total assistance on some items. A consistently low score would emerge, reducing the ability of the tool to measure variability or change in a palliative population.
Two measures, the Karnofsky Performance Status scale (KPS) 7 and the Eastern Cooperative Oncology Group Performance Status scale (ECOG), 8 are widely used in oncology and palliative care. They have been used in research to classify patients into groups based on performance and to measure the outcome of medical interventions. The KPS, first developed in 1948, has since been used to measure functional status in cancer, 9 predict prognosis in terminal illness, 10 and determine outcomes in geriatric populations. 11 The KPS numerically describes in an easily administered, global score, the patients' ability to carry out normal activity and work, their need for a certain amount of custodial care, or their dependence on constant medical care. The KPS is an objective scale based on clinical assessment by health-care providers. Similarly, the ECOG provides a single score that describes the patients' activity from fully active [0] to completely disabled [4] . Studies on the ECOG are sparse. 12 Clinical experience of the first author 13 suggests that the scores on the KPS and ECOG for patients with terminal cancer tend to cluster at the low end of the scales. The 'floor effect' limits their sensitivity to change. Furthermore, the scales do not evaluate the functions assessed and treated in rehabilitation.
Anderson et al. 14 identified a need for an assessment tool which accurately reflects the changing physical status of palliative patients. They developed the Palliative Performance Scale, a new tool based on the KPS. The Palliative Performance Scale guides assessment of functional performance and provides a framework for measuring the progressive decline in palliative patients. 14 Assessment variables are related to physical deterioration: intake, mobility, self-care and level of consciousness. Developed as an extension to the KPS, the Palliative Performance Scale is not designed to evaluate function from a rehabilitation perspective.
The Edmonton Functional Assessment Tool (EFAT) is a rehabilitation outcome measure designed for use in palliative care. It was developed in an attempt to alleviate some of the shortcomings of existing performance status measures used in a palliative setting. The intent of the EFAT was to describe and document the functional status of cancer patients throughout the palliative stage of their disease. The EFAT may be used as an assessment of everyday management of palliative patients. It evaluates the extent to which patients are able to interact and mobilize even when severely limited by their disease. Preliminary evaluation of the psychometric properties of the EFAT indicated acceptable reliability and support for construct validity. 13 The research also led to changes in some of the items 13 and a revised version (EFAT-2) (Table 1) of the original tool. Although the intent of the EFAT did not change, the previously established reliability was no longer applicable. This study sought to establish inter-rater reliability of the revised version, the EFAT-2.
The EFAT-2 consists of two parts. Part 1 contains 10 items describing symptoms, that the patients may experience and functions that they are required to perform. These include communication, mental status, pain, dyspnoea, balance, mobility, locomotion, fatigue, motivation and activities of daily living (ADL). Part 2 is a single item that summarizes the performance status after the 10 specific functions are assessed. Four descriptors are used to score each item. Each descriptor outlines criteria that the patient must meet, to be given a rating from 0 (independent) to 3 (total loss of function).
To administer the EFAT-2 clinicians ask patients to perform each function (item) in turn, and directly observe and rate the performance. The EFAT-2 measures what the patient can do on request, not what he or she ought to be able to do. All items are evaluated. The total score on the EFAT-2 is 30. No provision is made to consider an item 'not applicable' or 'not evaluated'. The 3 rating is to be used if an item cannot be assessed or if it is unsafe to assess it. Four items (pain, fatigue, mental status and motivation) are subjective and 'performance' is not directly observable. Criteria for Inter-rater reliability using the Edmonton Functional Assessment Tool 511 rating the subjective items are provided in the guidelines to facilitate consistency in rating. In many studies on inter-rater reliability, raters undergo a period of formal training prior to rating to ensure that their methods are standardized (formally trained). However when standardized definitions are used and the same performance is viewed, [15] [16] [17] [18] different raters will not always be in agreement on the scoring of a particular behaviour. 15 Like many instruments used in clinical practice, the EFAT-2 was intended to be used by clinicians who teach themselves the administration procedures by reading the test manual (self-trained). A test manual containing standardized guidelines for administration has been developed to facilitate use of the EFAT-2.
The purpose of this study was to establish the inter-rater reliability of the EFAT-2 and to determine whether both formally trained and self-trained physical therapists had an acceptable level of interrater reliability.
Method

Subjects and raters
Two independent samples of 36 cancer patients were accrued from three palliative care units in Edmonton. Sample 1 included subjects exclusively from a continuing care facility, while sample 2 also included eight subjects awaiting transfer to a continuing care palliative unit. The sample sizes were based on an alpha level of 0.05, power of 80% and a minimum acceptable reliability coefficient of 0.80. 19 Patients were entered into the study if they had a life expectancy of at least one month, were comfortable and willing to participate, and provided signed informed consent. All patients admitted to the study were experiencing progressive disease where the focus of care was on comfort and improving quality of life. They required active care to alleviate distressing symptoms related to physical, psychosocial and spiritual needs. In addition, patients on continuing care palliative units could not be managed at home, did not require acute or tertiary case, had an expected length of stay of approximately two months, were aged over 18 years, and had accepted a no code status. Patients with questionable competency or with limited understanding of the English language were excluded from this study.
Four experienced physical therapists acted as raters for the study. One physical therapist had previous clinical experience using the EFAT-2. One pair (R1, R2) trained themselves in the use of the EFAT-2. The other pair (R3, R4) was formally trained by the principal investigator.
Procedures
The study addressed the issue of reliability. Ethical approval was obtained from the Caritas Health Group and St Joseph's Auxiliary Hospital, Edmonton, Alberta, Canada.
The formally trained raters read the test manual, discussed the guidelines with the principal investigator, and then scored case histories and patients. Prior to beginning the study it was established that once the raters were within 2 points of the principal investigator on total score they would be deemed accurate and data collection would begin.
Once the raters had read the test manual, they requested clarification of the scoring. The principal investigator reviewed the guidelines and encouraged the raters to refer to the long descriptors from the test manual when scoring a patient on the EFAT-2 items.
Three case scenarios were used to practise scoring of the EFAT-2. The scenarios included the age and medical history of a patient and outlined the patient's performance on each item of the EFAT-2. The raters scored the scenarios independently and then discussed the results with the principal investigator. The total score for R4 was within 2 points of the principal investigator on all scenarios. R3 agreed with the principal investigator on the total score of one scenario but was different by 3 points on the others. Three items had disparate scoring: dyspnoea, fatigue and motivation. The criteria for scoring these items were reviewed with both raters and a consensus on scoring was obtained.
Lastly, the principal investigator administered the EFAT-2 to patients in a clinical setting and the raters scored the patients independently. The scoring was reviewed after each patient. Both raters were within 2 points of the principal investigator on total score for the first three patients. The raters were deemed accurate, training was discontinued and data collection commenced.
In contrast, the self-trained raters read the test manual, taught themselves to administer the EFAT-2 and then administered the test to two or three patients. Once this was accomplished, data collection began.
All raters were asked to administer the EFAT-2 as per instructions for use in the test manual. They were also provided with an addendum to the guidelines clarifying scoring criteria of pain, mental status, dyspnoea, fatigue, motivation and performance status.
The principal investigator was responsible for obtaining potential subjects for the study, explained the purpose and methodology of the study to them and obtained their consent. They were admitted into the study once their symptoms were controlled. As patients were enrolled they were assigned a study number to ensure confidentiality. In general, subjects were assessed during the same week that they were admitted to the study.
Two similarly trained raters used the EFAT-2 to assess subjects simultaneously on one occasion. One rater administered the EFAT-2 while the other rater observed. They scored the subject independently of each other and were asked not to discuss the scores until all data collection was complete. Subjects were also asked to refrain from discussing their performance with the raters. The principal investigator offered feedback to the subjects after the EFAT was administered. Because the administrator of the EFAT-2 can influence the test, raters were randomized as administrator or observer for each patient before the initiation of the study. The administration of the total EFAT-2 took approximately 15-20 min.
Statistical analysis
The two samples were compared on basic demographics. A t-test was used to determine differences between the two samples for age and Mini Mental Status Examination (MMSE) total scores. A chisquared test was used to determine whether a difference existed between the two samples on gender and diagnosis.
An intraclass correlation [ICC (1,1)], 20 95% confidence interval 21 and standard error of measurement (SEM) were used to examine the inter-rater reliability of the similarly trained raters. These were calculated from one-way repeated measures analyses of variance (ANOVAs), which also determined the significance of the difference between raters. The Kappa statistic, a chance-corrected measure of agreement, was used to determine the agreement between similarly trained raters on individual items. All data were analysed using an alpha level statistical significence of p < 0.05.
Results
Descriptive data for the subjects are presented in Table 2 . Although the two samples differed in age, they were similar regarding gender, diagnosis and cognitive status. Table 3 demonstrates high intraclass correlation coefficients and low SEMs. However, the ANOVA results indicated a significant difference between the formally trained raters (Table 4 ). This difference is due to the higher systematic error (MS between measures) of sample 2 compared with sample 1. An examination of the mean scores (Table 3) indicates that R3 scored consistently higher than R4.
The Kappa values and percentages of agreement within the rater pairs on individual items are presented in Table 5 . Percentage of agreement is the number of subjects on which the raters agreed as a proportion of all subjects studied. The average
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Discussion
The results of the present study generally indicate good inter-rater reliability for both formally trained and self-trained raters using the EFAT-2. The high intraclass correlations indicates consistency between the raters. The narrow range of the confidence interval for the intraclass correlations and the low 514 T Kaasa et al. SEMs also support good inter-rater reliability. The Kappa values on 9/10 items of the EFAT-2 suggest acceptable to high levels of rater agreement on the individual items. However, the results of the ANOVA indicate that there was a small but significant systematic difference between the formally trained raters. Thus, although reliability is good, it could be even better if reasons for the systematic error could be determined and eliminated.
Although the intraclass correlation and its confidence interval provide an estimate of reliability and the strength of the magnitude of the reliability, they do not provide estimates of the precision of the measurement. The precision of measurement is estimated by the SEM, 17, 22 which is expressed in the same units as the original measurement. 22 Clinically, the SEM is valuable because it is like a standard deviation and can be used to form a band or confidence interval around a given score. For example, if R1 (SEM = 1.09) administered the EFAT-2 and obtained a total score of 14, the true score would be contained within the interval 12.91-15.09 (± 1 SEM) 68% of the time. Similarly, one can be certain that the true score would be contained within the range 11.82-16.18 (± 2 SEM) 96% of the time. The SEM is useful for a physical therapist because in order to state that a subject's condition has changed it is necessary to know the amount of change that might be expected from measurement error alone.
Providing estimates of both relative reliability and absolute reliability (precision) is important. 22, 23 A small SEM means that the observed score is close to the true score. A high intraclass correlation indicates that the majority of the variance in the scores results from variation in the subjects as opposed to measurement error or differences in scoring by the raters.
As previously indicated, there was a systematic difference between the formally trained raters. One possible explanation is the difference in their clinical backgrounds. R3 was a geriatric specialist used to working with higher functioning patients, and R4 a generalist with most recent experience in palliative care. It is possible that R3 graded 'harder' because her reference group was better functioning than the reference group used by R4. Because the differences in scoring persisted across repeated administrations using the same instrument and affected the raters' scores in a constant fashion, they are systematic errors of measurement.
It is critical to acknowledge systematic error. For example, if R3 and R4 used the EFAT-2 in a pre/post-design study, where R3 saw subjects for the 'pre' measurement and R4 for the 'post' measurement, the results might suggest that the individuals had improved. In fact, the 'improvement' may be because of the lower scoring of the second rater. One of the advantages of using an intraclass correlation and reporting the ANOVA results is that systematic error is easily detected. Additional training of the assessors could then reduce the bias, or scores could be adjusted to account for the bias.
The advantage of the Kappa coefficient is its correction or 'adjustment' for the amount of agreement that can be expected to occur by chance alone. According to Landis and Koch, 24 Kappa values at or above 0.50 represent a good level of agreement.
The Kappa values obtained in the present study indicate that most of the individual items of the EFAT-2 could be reliably assessed (range 0.53-0.96) by the rater pairs. The communication and motivation items are interesting exceptions.
The lower Kappa values for the communication item reflect a lack of variability in scoring. Kappa values are affected by the 'prevalence' of the attribute to be measured. 25 In sample 1, both raters used only the 0 and 1 ratings. In sample 2, category 3 was not used. Lack of variability increased the likelihood of the raters agreeing by chance. Hence, the Kappa statistic, corrected for chance agreement, is low, although the percentage of agreement is high.
Motivation displayed a lower Kappa value in sample 2. A possible explanation might be the differences in the circumstances of the raters. The selftrained raters were employed in the facility where the rating took place and were perhaps more familiar with the patients on the unit. The formally trained raters, meeting subjects for the first time, had difficulty in grasping each subject's motivation level based on one 15-20 min interaction.
Kappa values have improved compared to the original EFAT. 13 Three main reasons may account for the improvement in reliability: the method of test administration, the changes in the EFAT items and the clarification of the guidelines for administration. Each issue is addressed below.
Testing for inter-rater reliability of the original version of the EFAT consisted of two independent raters assessing subjects within 24 h of each other. When observations are made at two separate times, the variability attributed to the raters and the variability within subjects cannot be separated. In the present study, the raters observed the same subject performance and each other administering the tool. A change in the subject is eliminated as a source of measurement error. 15 The physical therapists may have become more reliable by observing each other, becoming more alike in their test administration. Hence, reliability may increase.
Revisions to some EFAT items followed preliminary research 13 (Table 1 ) and criteria developed provided consistency in rating subjective items: pain, mental status, fatigue and motivation. Guidelines for use of the EFAT-2 were established to provide consistent administration of the test. The increased objectivity of the items and written guidelines may have contributed to the increase in reliability found with the EFAT-2.
The EFAT-2 was designed to measure a specific performance, i.e what the individual does on demand. Discussion with the raters suggests that the self-trained raters used the tool to reflect 'usual' performance of the subject for the balance, mobility and locomotion items. A discrepancy in interpretation of scoring taken by the self-trained raters raises a concern when the tool is used for research purposes. When using the EFAT-2, the test (specific) performance should be scored. If there is a discrepancy between the test performance and usual performance of a patient, the reason for the difference should be explored. The discrepancy is not a reflection of the measurement properties of the tool but may have relevance in a clinical setting. For example, if a patient regularly walks about the unit but is unwilling to walk when tested on the EFAT-2, the reason for refusing should be explored. If there is a problem with symptom control, psychosocial issues or physical concerns may be revealed and addressed.
Despite the differences between the pairs of raters, both pairs demonstrated excellent inter-rater reliability. This would suggest that therapists with a variety of clinical experience and different backgrounds might obtain acceptable intraclass correlations when using the EFAT-2. Based on the two samples, the EFAT-2 can be a reliable instrument used on a regular basis or as a research tool where clinicians or research assistants are seeing subjects for the first time. The latter use may apply in some clinical settings. For example, in a rural setting, a therapist may not work in the same facility every day of the week. The EFAT-2 could be used reliably on a weekly basis to monitor the ongoing functional status of patients.
One way of facilitating consistent interpretation by all users of the EFAT-2 would be to use a training video. All individuals using the tool would then view the same performance of an individual and be taught the same interpretation of the performance for scoring. The distinction between test performance and usual performance could be made.
Conclusion
The EFAT-2 has an excellent level of inter-rater reliability when used by physical therapists in the same manner as in this study. Both self-trained and formally trained raters may obtain acceptable levels of reliability using the EFAT-2. Nonchance agreement on individual items for similarly trained raters was acceptable for 9/10 items. Further examination of the EFAT-2 with regard to test-retest reliability, responsiveness and predictive validity should be done. The EFAT-2 should be compared to other measures of functional status. Subjecting the EFAT-2 to the rigours of multisite testing to examine its psychometric properties further is recommended.
